Tender for The contracting of supplies of reagents, antibodies, columns, media and materials necessary for immunomagnetic cell separation, advanced cell culture and cell processing procedures necessary for the realization of the research project IC23/00041"Intratumor administration of modified t cells with the chimeric receptor (CAR) versus the p32 antigen in high-grade gliomas in progression. Phase 1 clinical trial with dose escalation financed by the Carlos III Institute of Health (ISCIII) and co-financed by the European Union to be awarded by the Biomedical Research Foundation of the 12th October University Hospital by procedure (SARA) single price criterion. FIB 2025/033.